Smurf2 inhibition enhances chemotherapy and radiation sensitivity in non-small-cell lung cancer

Lung cancer has been the most common cancer worldwide for several decades. The outcomes of patients with locally advanced lung cancer remain dismal, and only a minority of patients survive more than 5 years. However, tumor therapeutic resistance mechanisms are poorly studied. Identification of thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaudhary, Kunal R., Kinslow, Connor J., Cheng, Haiying, Silva, Jose M., Yu, Jiyang, Wang, Tony. J., Hei, Tom K., Halmos, Balazs, Cheng, Simon K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203496/
https://www.ncbi.nlm.nih.gov/pubmed/35710591
http://dx.doi.org/10.1038/s41598-022-14448-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203496/
https://www.ncbi.nlm.nih.gov/pubmed/35710591
http://dx.doi.org/10.1038/s41598-022-14448-8

Ejemplares similares